RedHill Biopharma (RDHL) FCF Margin Growth (3y) (2015 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) FCF Margin Growth (3y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 213.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -291.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,879.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -263.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1,258.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 46,147.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 460.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -824.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -51,777.00 |
| Mar 31, 2023 | 78,348.00 |
| Dec 31, 2022 | 85,127.00 |
| Sep 30, 2022 | 60,054.00 |
| Jun 30, 2022 | 57,110.00 |
| Mar 31, 2022 | 40,172.00 |
| Dec 31, 2021 | 53,527.00 |
| Sep 30, 2021 | 29,143.00 |
| Jun 30, 2021 | 26,944.00 |
| Mar 31, 2021 | 32,866.00 |
| Dec 31, 2020 | 64,882.00 |
| Sep 30, 2020 | 64,735.00 |
| Jun 30, 2020 | 192,114.00 |
| Jun 30, 2019 | 57.14 Mn |
| Jun 30, 2018 | 46.71 Mn |
| Mar 31, 2018 | 33.66 Mn |
| Dec 31, 2017 | 58.94 Mn |
| Sep 30, 2017 | 9.43 Mn |
| Jun 30, 2017 | 10.20 Mn |
| Jun 30, 2016 | -51.93 Mn |